Document Detail


Generation of the first structure-based pharmacophore model containing a selective “zinc binding group” feature to identify potential glyoxalase-1 inhibitors.
MedLine Citation:
PMID:  23174893     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Within this study, a unique 3D structure-based pharmacophore model of the enzyme glyoxalase-1 (Glo-1) has been revealed. Glo-1 is considered a zinc metalloenzyme in which the inhibitor binding with zinc atom at the active site is crucial. To our knowledge, this is the first pharmacophore model that has a selective feature for a “zinc binding group” which has been customized within the structure-based pharmacophore model of Glo-1 to extract ligands that possess functional groups able to bind zinc atom solely from database screening. In addition, an extensive 2D similarity search using three diverse similarity techniques (Tanimoto, Dice, Cosine) has been performed over the commercially available “Zinc Clean Drug-Like Database” that contains around 10 million compounds to help find suitable inhibitors for this enzyme based on known inhibitors from the literature. The resultant hits were mapped over the structure based pharmacophore and the successful hits were further docked using three docking programs with different pose fitting and scoring techniques (GOLD, LibDock, CDOCKER). Nine candidates were suggested to be novel Glo-1 inhibitors containing the “zinc binding group” with the highest consensus scoring from docking.
Authors:
Qosay Al-Balas; Mohammad Hassan; Buthina Al-Oudat; Hassan Alzoubi; Nizar Mhaidat; Ammar Almaaytah
Related Documents :
23707773 - Identification of putative estrogen receptor-mediated endocrine disrupting chemicals us...
6096403 - Cobalamin and folate binding proteins in human tumour tissue.
14719803 - Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor.
Publication Detail:
Type:  Journal Article     Date:  2012-11-22
Journal Detail:
Title:  Molecules (Basel, Switzerland)     Volume:  17     ISSN:  1420-3049     ISO Abbreviation:  Molecules     Publication Date:  2012  
Date Detail:
Created Date:  2012-11-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100964009     Medline TA:  Molecules     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  13740-58     Citation Subset:  IM    
Affiliation:
Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan. qabalas@just.edu.jo.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Synthesis and antiproliferative activity of ammonium and imidazolium ionic liquids against T98G brai...
Next Document:  Palladium-catalyzed multicomponent synthesis of 2-imidazolines from imines and Acid chlorides.